Global Head, Clinical and Precision Medicine Imaging Novartis Institutes for Biomedical Research Boston, Massachusetts
During this session we will review the opportunities and challenges of using imaging biomarkers in clinical drug development, based on specific examples.
By the end of this session, you will have a better understanding of:
• The role of imaging within the broader context of clinical biomarkers
• Reproducibility and scalability of imaging biomarkers in drug development
• The intersection of imaging biomarkers and AI methods
Learning Objectives:
Upon completion, the participants will be able to better understand the role of imaging within the broader context of clinical biomarkers.
Upon completion, the participants will be able to better understand reproducibility and scalability of imaging biomarkers in drug development.
Upon completion, the participants will be able to better understand the intersection of imaging biomarkers and AI methods.
